• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (COSTA RICA) Style 115 Silicone Gel Filled Breast Implant; prosthesis, breast, noninflatable, internal, silicone gel-filled

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (COSTA RICA) Style 115 Silicone Gel Filled Breast Implant; prosthesis, breast, noninflatable, internal, silicone gel-filled Back to Search Results
Catalog Number 115-253
Medical Device Problem Codes Device Appears to Trigger Rejection (1524); Material Rupture (1546)
Health Effect - Clinical Code Capsular Contracture (1761)
Date of Event 11/17/2025
Type of Reportable Event Serious Injury
Event or Problem Description
Patient reported "rupture" and "capsular contracture baker grade unknown".This record is for the left side.Device remains implanted.
 
Additional Manufacturer Narrative
The event of capsular contracture is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.Reason for reoperation: capsular contracture baker grade unknown.A review of the device history record has been completed.No deviations or non-conformances noted.
 
Additional Manufacturer Narrative
Reason for reoperation: capsular contracture baker grade iv.
 
Event or Problem Description
Healthcare professional later reported capsular contracture baker grade iv.
 
Event or Problem Description
Patient reported "rupture" and "capsular contracture baker grade unknown".Later healthcare professional reported "capsular contracture baker grade iv".Later healthcare reported "hole in inner capsule", "any creases", "device enclosed within a white "double capsule", this inner capsule was very adherent to underlying textured, ruptured implant, removed "en bloc" then opened up off-table to examine implant".Singulair was prescribed as treatment.This record is for the left side.Device was explanted.
 
Additional Manufacturer Narrative
Additional, changed, and/or corrected data: b5, d6b, h6.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
Style 115 Silicone Gel Filled Breast Implant
Common Device Name
prosthesis, breast, noninflatable, internal, silicone gel-filled
Manufacturer (Section D)
ALLERGAN (COSTA RICA)
900 parkway global park
zona franca
la aurora de heredia
CS 
Manufacturer (Section G)
Allergan (Costa Rica)
900 parkway global park
zona franca
la aurora de heredia
CS  
Manufacturer Contact
terry ingram
2525 dupont drive
irvine, CA 92612
+1(847)936-6324
MDR Report Key24305986
Report Number9617229-2026-02688
Device Sequence Number14756041
Product Code FTR
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
P020056
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2011
Device Explanted Year2026
Reporter Type Manufacturer
Report Source Consumer,Health Professional
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date (Section B) 08/19/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date01/15/2015
Device Catalogue Number115-253
Device Lot Number1811769
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer07/20/2026
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/26/2026
Supplement Date Received by Manufacturer04/15/2026
06/01/2026
07/29/2026
Not provided
Initial Report FDA Received Date02/10/2026
Supplement Report FDA Received Date05/11/2026
06/29/2026
08/14/2026
08/19/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured02/17/2010
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age52 YR
Patient SexFemale
Patient Weight110 LB
Patient RaceWhite
-
-